Thermogenesis Corp. (NASDAQ KOOL)

Last Trade:	3.13
Trade Time:	4:00PM ET
Change:	0.44 (16.36%)

hermoGenesis Corp. has received three U.S. patents for its AutoXpress stem cell processing system and its CryoSeal surgical glue devices.

AutoXpress, marketed by GE Healthcare, separates stem cells from umbilical cord blood and bone marrow. Doctors use blood and bone marrow stem cells to treat leukemia, lymphoma and blood diseases like sickle cell anemia. The company has other patents pending for AutoXpress.

The New York Blood Center, which is compiling a national umbilical cord blood stem cell bank, uses the AutoXpress device. It is also used by private blood banks contracted by parents to store newborns' cord blood in case the children develop blood diseases in the future.